Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1463-1326.2002.00181.xPMID 11874442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population.

  2000cited by this paper
• Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.

  2000cited by this paper
• Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

  2000cited by this paper
• Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

  1999cited by this paper
• Current and potential drugs for treatment of obesity.

  1999cited by this paper
• The impact of pharmacotherapy on weight management in type 2 diabetes

  1999cited by this paper
• Sibutramine produces dose-related weight loss.

  1999cited by this paper
• Thermogenic effects of sibutramine in humans.

  1998cited by this paper
• Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group.

  1998cited by this paper
• Sibutramine reduces food intake in non-dieting women with obesity.

  1998cited by this paper
• Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study

  1998cited by this paper
• Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.

  1998cited by this paper
• Longitudinal Studies to Determine the Effect of Body Fat Rate Reduction on Blood Pressure

  1998cited by this paper
• Effect of metformin on food intake in obese subjects

  1998cited by this paper
• Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

  1998cited by this paper
• Abdominal adiposity and coronary heart disease in women.

  1998cited by this paper
• Impairment of health and quality of life in people with large waist circumference.

  1998cited by this paper
• Sibutramine: a review of the pharmacology of a novel anti-obesity agent.

  1997cited by this paper
• Body weight and mortality among women.

  1997cited by this paper
• What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes.

  1997cited by this paper
• A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention

  1997cited by this paper
• Pharmacotherapy in the management of obesity.

  1997cited by this paper
• Long-term drug treatment of obesity in a private practice setting.

  1997cited by this paper
• An overview of metformin in the treatment of type 2 diabetes mellitus.

  1997cited by this paper
• Obesity, levels of lipids and glucose, and smoking among Navajo adolescents.

  1997cited by this paper
• Obesity and cardiovascular disease.

  1996cited by this paper
• Obesity and cardiovascular disease.

  1996cited by this paper
• Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity.

  1996cited by this paper
• A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity.

  1996cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

  1996cited by this paper
• Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women

  1995cited by this paper
• Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years.

  1995cited by this paper
• Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.

  1995cited by this paper
• Body weight and mortality among women.

  1995cited by this paper
• Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects.

  1995cited by this paper
• Weight loss attempts in adults: goals, duration, and rate of weight loss.

  1992cited by this paper
• Epidemiology and natural history of gallstone disease.

  1991cited by this paper
• Epidemiology and Natural History of Gallstone Disease

  1990cited by this paper
• The health consequences of moderate obesity.

  1981cited by this paper

• Effects of oral antidiabetic agents on the renin–angiotensin–aldosterone system

  2025cites this paper
• Effects of antidiabetic drugs on the level of serum uric acid in patients who have type 2 diabetes

  2025cites this paper
• Effects of bariatric surgery on hyperuricemia and gout: a systematic review of the literature

  2024cites this paper
• A systematic review, ANCOVA meta-analysis, and meta-regression of clinical trials: Orlistat and body mass index of overweight and obese patients

  2024cites this paper
• The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials

  2024cites this paper
• The use of orlistat in diabetes: An educational article and expert opinion

  2023cites this paper
• Mechanisms of ageing: growth hormone, dietary restriction, and metformin.

  2023cites this paper
• Metformin Treatment Leads to Increased HIV Transcription and Gene Expression through Increased CREB Phosphorylation and Recruitment to the HIV LTR Promoter

  2023cites this paper
• Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis

  2023cites this paper
• The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis

  2022cites this paper
• Therapeutic and Adverse Effects of Metformin in Diabetes: A Review Article

  2022cites this paper
• Ovulation induction techniques in women with polycystic ovary syndrome

  2022cites this paper
• EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY

  2022cites this paper
• The comparison of treatment with orlistat and orlistat plus metformin in relation to insulin resistance and weight loss

  2022cites this paper
• The effect of visfatin rs2110385 gene polymorphism over oral antidiabetic drug response

  2021cites this paper
• Biguanides drugs: Past success stories and promising future for drug discovery.

  2021cites this paper
• INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"

  2021cites this paper
• The effects of high-intensity interval training and orlistat on selected adipokines and cytokines in obese women

  2021cites this paper
• Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis.

  2021cites this paper
• Ожирение: «перекрестки» мнений, знаний и возможностей

  2020cites this paper
• Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway

  2020cites this paper
• Metformin: A review of its therapeutic efficacy and adverse effects

  2020cites this paper
• Obesity: The Crossroads of Opinion, Knowledge, and Opportunity

  2020cites this paper
• OBESITY: CLINICAL AND PATHOGENETIC JUSTIFICATION OF PREVENTION AND TREATMENT

  2020cites this paper
• Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study.

  2020cites this paper
• Clinical and pathogenetic rationale for the prevention and treatment of obesity

  2020cites this paper
• Effects of metformin in obesity treatment in different populations: a meta-analysis

  2020cites this paper
• Role Of Metformin In Infection

  2020cites this paper
• Derivación biliopancreática en el tratamiento quirúrgico de la obesidad mórbida. Consecuencias metabólicas a largo plazo

  2019cites this paper
• A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis

  2018cites this paper
• Effect of Some Slimming Drugs on Some Biochemical and Physiological Parameters of Albino Rats

  2018cites this paper
• The effect of orlistat and weight loss diet on plasma ghrelin and obestatin

  2018cites this paper
• ASSOCIATION BETWEEN SERUM URIC ACID AND C-REACTIVE PROTEIN WITH METABOLIC SYNDROME RISK FACTORS -A CROSS SECTIONAL STUDY

  2018cites this paper
• Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion.

  2018cites this paper
• A story of metformin‐butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?

  2017cites this paper
• Exploratory Literature Meta‐Analysis to Characterize the Relationship Between Early and Longer Term Body Weight Loss for Antiobesity Compounds

  2017cites this paper
• Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.

  2017cites this paper
• Metabolic Syndromes Improvement and Its Related Factors among Health Checkup Examinees in a University Hospital

  2016cites this paper
• The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study

  2016cites this paper
• Exercise in a Pill: The Latest on Exercise-Mimetics

  2016cites this paper
• ARTICLE FROM O&G MAGAZINE AND INVITED COMMENTARY Polycystic Ovarian Syndrome

  2016cites this paper
• The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

  2015cites this paper
• Relationship of Gout and Dyslipidemia

  2015cites this paper
• Tratamento com metformina restaurou danos metabólicos causados pela obesidade, mas induziu a resposta inflamatória hepática

  2015cites this paper
• Are the recent secular increases in the waist circumference of adults independent of changes in BMI?

  2015cites this paper
• Lipoprotein(a): Its relevance to the pediatric population.

  2015cites this paper
• Metformin—mode of action and clinical implications for diabetes and cancer

  2014cites this paper
• Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet

  2014cites this paper
• The effect of bariatric surgery on gout: a comparative study.

  2014cites this paper
• Recommendations for severe hypertriglyceridemia treatment, are there new strategies?

  2014cites this paper
• La metformina nell'obesità associata alla sindrome metabolica Razionale per l'uso della formulazione slow release

  2014cites this paper
• An intervention programme for management of overweight and obese Nigerians in Lagos State, Nigeria

  2014cites this paper
• [Efficacy of metformin in abdominal obesity].

  2014cites this paper
• Bariatric surgery as urate-lowering therapy in severe obesity

  2014cites this paper
• Uric acid and diabetes: Is there a link?

  2013cites this paper
• Effect of Concomitant Administration of Trospium Chloride Extended Release on the Steady-State Pharmacokinetics of Metformin in Healthy Adults

  2013cites this paper
• Dietary stimulators of the PGC-1 superfamily and mitochondrial biosynthesis in skeletal muscle. A mini-review

  2013cites this paper
• Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet

  2013cites this paper
• Emerging Concepts in Metformin Therapy: Hyperglycaemia and Beyond

  2013cites this paper
• Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study

  2013cites this paper
• Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet

  2013cites this paper
• Obesity and type 2 diabetes: which patients are at risk?

  2012cites this paper
• Metformin and its clinical use: new insights for an old drug in clinical practice

  2012cites this paper
• A study of the use of drugs in the treatment of obesity among adult females.

  2012cites this paper
• Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity

  2012cites this paper
• Pharmacotherapy for Obesity

  2012cites this paper
• Current Management Strategies for Coexisting Diabetes Mellitus and Obesity

  2012cites this paper
• What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.

  2012cites this paper
• Effects of 1‐year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes

  2012influential citation
• Current updates in the medical management of obesity.

  2012cites this paper
• Sibutramine versus Metformin: assessment of anthropometric, lipid and glycemic parameters in obese and overweight high-risk patients

  2012cites this paper
• Orlistat

  2012cites this paper
• Genome-wide association analyses identify 18 new loci associated with serum urate concentrations

  2012cites this paper
• Screening for and Management of Obesity and Overweight in Adults

  2011influential citation
• Etiology and pathogenesis of gout

  2011cites this paper
• Effectiveness of Primary Care–Relevant Treatments for Obesity in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force

  2011cites this paper
• The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents

  2011cites this paper
• Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.

  2011cites this paper
• Effects of glibenclamide and metformin on serum uric acid level in patients with type II diabetes mellitus

  2011cites this paper
• Present and Future: Pharmacologic Treatment of Obesity

  2011cites this paper
• Efeito da sibutramina na redução do peso e no perfil metabólico em indivíduos obesos de uma população brasileira

  2010cites this paper
• Estudio comparativo para evaluar la eficacia y seguridad de orlistat vs placebo en pacientes adultos de la Ciudad de México

  2010cites this paper
• Tackling obesity: new therapeutic agents for assisted weight loss

  2010cites this paper
• Tackling obesity: new therapeutic agents for assisted weight loss

  2010cites this paper
• Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women

  2010cites this paper
• Revista Brasileira de Obesidade, Nutrição e Emagrecimento

  2010cites this paper
• Tackling obesity: new therapeutic agents for assisted weight loss

  2010cites this paper
• Long‐term changes in blood pressure following orlistat and sibutramine treatment: a meta‐analysis

  2010cites this paper
• Tackling obesity: new therapeutic agents for assisted weight loss

  2010cites this paper
• Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.

  2010cites this paper
• EPIDEMIOLOGY CLINICAL FEATURES AND COMORBIDITIES IN GOUT

  2010cites this paper
• Metformin increases plasma ghrelin in Type 2 diabetes.

  2009cites this paper
• Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use.

  2009cites this paper
• Effects of orlistat, alone or combined with hypolipidemic drugs, on cardiovascular risk factors

  2009cites this paper
• What are the risks and the benefits of current and emerging weight-loss medications?

  2009cites this paper
• Lipid-lowering drugs acting at the level of the gastrointestinal tract.

  2009cites this paper
• The use of sibutramine in the management of obesity and related disorders: An update

  2009cites this paper
• Orlistat: current status in clinical therapeutics

  2009cites this paper
• MORE PRO‐ACTIVITY IS REQUIRED IN THE BATTLE AGAINST OBESITY IN MEN

  2009cites this paper
• Variation in the visfatin gene may alter the required dosage of oral antidiabetic agents in type 2 diabetic patients

  2009cites this paper